United Therapeutics: Competitive Advantages At Such Cheap Multiples Scream Buy
…
350,550€
0,10%
Echtzeit-Aktienkurs United Therapeutics Corp.
Bid:
Ask:
Nachrichten zur United Therapeutics Corp. Aktie
United Therapeutics: One To Believe In Despite Competitive Threats
…
United Therapeutics Q3 Earnings & Sales Beat Estimates
UTHR reports better-than-expected results in third-quarter 2024 on the back of strong demand for its treprostinil medications, especially Tyvaso.…
Futures: Nvidia Rallies To New Highs
Stocks to watch include Uber Technologies and United Therapeutics.…
Futures Lower As Nvidia, Tesla Fall
Texas Roadhouse, Uber and United Therapeutics are among the best stocks to watch.…
United Therapeutics könnte mit neuen TYVASO-Indikationen und künstlichen Organen seine Umsätze auf 16 Mrd. USD vervielfachen. Flat Base-Breakout!
United Therapeutics (UTHR) ist auf die Entwicklung und Kommerzialisierung von Produkten zur Behandlung der pulmonal-arterielle Hypertonie (PAH) spezialisiert. Vor allem…
Opening Bell: Wall Street startet behauptet; UnitedHealth, Goldman Sachs, Citigroup, United Therapeutics im Fokus
Am Dienstag sieht es zunächst nach einem ruhigen Handelsauftakt an der New Yorker Wall Street aus. Zum Wochenauftakt hatte der…
Opening Bell: Citigroup, Goldman Sachs, United Health, Walgreens, Trump Media, United Therapeutics
Der Rekordlauf an der Wall Street setzte sich auch zu Wochenbeginn fort. Erneut erklommen Dow Jones und S&P 500 neue…
Court Finds United Therapeutics’ Interference with Launch of Generic Treprostinil Injection Caused Losses of More Than $137 Million
MORRISVILLE, N.C., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) (Liquidia), a biopharmaceutical company developing innovative…
Is United Therapeutics (UTHR) a Solid Growth Stock? 3 Reasons to Think "Yes"
United Therapeutics (UTHR) is well positioned to outperform the market, as it exhibits above-average growth in financials.…
Liquidia surges after United Therapeutics request for preliminary injunction denied (update)
…
Earnings call: United Therapeutics reports strong Q1 with record revenue By Investing.com
Earnings call: United Therapeutics reports strong Q1 with record revenue…
United Therapeutics (UTHR) Q1 Earnings Top, Tyvaso Drives Sales
United Therapeutics (UTHR) first-quarter 2024 earnings and sales beat estimates. Tyvaso sales continue to drive the companys top line.…
United Therapeutics motion for restraining order over Liquidias Yutrepia denied
…
United Therapeutics CEO sells over $7 million in company stock By Investing.com
United Therapeutics CEO sells over $7 million in company stock…
United Therapeutics initiates $1 billion stock buyback By Investing.com
United Therapeutics initiates $1 billion stock buyback…
United Therapeutics: Neutral Stance On Tyvasos Patent Challenges And Future Growth Prospects
…
Benuvia Operations, LLC and Chromocell Therapeutics Corp. Announce Strategic Partnership to Advance Healthcare Solutions
AUSTIN. Texas, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Benuvia Operations, LLC (“Benuvia”), a leader in pharmaceutical innovation, and…
Earnings call: United Therapeutics reports record Q4 revenue, growth strategy By Investing.com
Earnings call: United Therapeutics reports record Q4 revenue, growth strategy…
United Therapeutics (UTHR) Q4 Earnings & Sales Beat Estimates
United Therapeutics (UTHR) fourth-quarter 2023 earnings and sales beat estimates. Tyvaso sales continue to drive the companys top line.…
United Therapeutics shares drop on earnings miss By Investing.com
United Therapeutics shares drop on earnings miss…
United Therapeutics GAAP EPS of $4.36 beats by $0.17, revenue of $614.7M beats by $38.83M
…
Anticompetitive Behavior At United Therapeutics
…
United Therapeutics: Cheap With Litigation Headwinds
…
BriaCell Reports Unprecedented Anti-Tumor Activity of its Next Generation Personalized Breast and Prostate Cancer Immunotherapies in Tumor Models at the 2023 SITC Annual Meeting; FDA Greenlights Bria-OTS™ IND
PHILADELPHIA and VANCOUVER, British Columbia, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT)…
United Therapeutics (UTHR) Q3 Earnings & Sales Beat Estimates
United Therapeutics (UTHR) third-quarter 2023 earnings and sales beat estimates. Tyvaso sales continue to drive the companys top line.…
United Therapeutics Q3 2023 Earnings Preview
…
Miromatrix Medical climbs 225% following $140m United Therapeutics bid
Shares in the artificial human organs specialist Miromatrix Medical Inc. jumped 25% in premarket trading following the announcement of its…
United Therapeutics to buy Miromatrix Medical for $3.25 per share
…
United Therapeutics to Acquire Miromatrix Medical
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C. and EDEN PRAIRIE, Minn., Oct. 30, 2023 (GLOBE NEWSWIRE) --…
: Miromatrix Medical stock soars after it agrees to be bought by United Therapeutics
Miromatrix Medical Inc.’s stock MIRO jumped 230% in premarket trades on Monday after the company agreed to be acquired by…
United Therapeutics Shifts Focus To Tyvaso DPI Amidst Generic Threat
…
United Therapeutics: Both Fundamental And Technical Analyses Justify A Buy Decision
…
XFRA ISIN CHANGE
Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenCA3794281053 Xtacy Therapeutics Corp. 26.09.2023 CA98423G1072 Xtacy Therapeutics Corp.…
Insiderhandel: EVP & GENERAL COUNSEL verkauft Aktien von United Therapeutics im Wert von 1.377.265$
Mahon, Paul A. - Vorstand - Tag der Transaktion: 2023-08-17...…
United Therapeutics (UTHR) Q2 Earnings & Sales Beat Estimates
United Therapeutics (UTHR) second-quarter 2023 earnings and sales beat estimates. Tyvaso sales continue to drive the companys top line....…
United Therapeutics (UTHR) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
While the top- and bottom-line numbers for United Therapeutics (UTHR) give a sense of how the business performed in the…
United Therapeutics (UTHR) Tops Q2 Earnings and Revenue Estimates
United Therapeutics (UTHR) delivered earnings and revenue surprises of 18.82% and 12.06%, respectively, for the quarter ended June 2023. Do…
United Therapeutics beats Q2 top and bottom line estimates
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
United Therapeutics Q2 2023 Earnings Preview
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 8-K UNITED THERAPEUTICS Corp For: Jul 24
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Liquidia Unable to Reverse Loss in United Therapeutics Patent Dispute
Liquidia Unable to Reverse Loss in United Therapeutics Patent Dispute...…
U.S. Federal Circuit Affirms All District Court Rulings in Patent Litigation
MORRISVILLE, N.C., July 24, 2023 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that the Court of…
Form 8-K/A UNITED THERAPEUTICS Corp For: Jun 26
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Liquidia falls 19% after patent win for United Therapeutics
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 8-K UNITED THERAPEUTICS Corp For: Jun 26
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Insiderhandel: EVP & GENERAL COUNSEL verkauft Aktien von United Therapeutics im Wert von 1.366.635$
Mahon, Paul A. - Vorstand - Tag der Transaktion: 2023-06-15...…
The Latest Analyst Ratings for United Therapeutics
Latest Ratings for UTHR
DateFirmActionFromTo Feb 2022WedbushMaintainsOutperform Feb 2022Ladenburg ThalmannMaintainsBuy Feb 2022BTIGInitiates Coverage OnNeutral
View…
United Therapeutics (UTHR) Q1 Earnings Beat Estimates
United Therapeutics (UTHR) delivered earnings and revenue surprises of 11.72% and 1.46%, respectively, for the quarter ended March 2023. Do…
Form 10-Q UNITED THERAPEUTICS Corp For: Mar 31
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…